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ABSTRACT 
Context: Pulmonary tuberculosis has been a major health problem in Golestan province 
of Iran. 
Aims: This descriptive cross-sectional study was performed to evaluate the frequency of 
coexisting medical conditions and their effects on some epidemiologic factors in patients 
with pulmonary tuberculosis. 
Setting and Design: This was a descriptive cross-sectional study. 
Methods and Material: Demographic information, time of admission in the hospital and 
coexisting medical conditions (diabetes, chronic renal failure/hemodyalysis, 
corticosteroids consumption and malignancies) were extracted from the patient's file. 
Statistical analysis used: Chi-square test was used to assess the relationship between 
variables. 
Results: Two hundred forty three patients with pulmonary tuberculosis during 5 years 
were studied. Out of all, 162 cases (66.7%) did not have any co-morbidities. Diabetes 
mellitus was found to be the most prevalent condition (23.05%) followed by chronic 
renal failure, corticosteroid consumption and malignancy ranking second, third and forth 
in the list (5.8%, 2.5% and 2 respectively). The mean age of the patients was 50.15±19 
years old. In the group without co morbidities, male/female ratio was 1.41/1, but co 
morbidity with diabetes was significantly more prevalent in females (p<0.05). 
Conclusions: We suggest screening of tuberculosis in patients with chronic renal failure 
and diabetes mellitus in our area. Also for patients with pulmonary tuberculosis, 
diabetes screening should be considered essential. 
Key Words: Pulmonary tuberculosis, Diabetes mellitus, Chronic renal failure, 
Corticosteroid consumption, Malignancy. 
Key Message: Pulmonary tuberculosis should be considered in the management of chronic 
diseases in our area. 
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tuberculosis across the globe is 3 million [2]. 
Frequent occurrence of co- existing morbidities in 
patients with tuberculosis is one of the important 
problems, as the odds ratio for the incidence of 
active tuberculosis followed by chronic renal 
failure (Hemodialysis), diabetes and 
immunosuppressive treatment, is estimated to be 
around 10-25, 2-4, 10 respectively. An anonymous 
        study in 2003 showed that rate of TB specially in 
immunodeficient patients and high risk groups
such as diabetes mellitus was higher than normal 
Introduction population [3], [4],[5],[6],[7], and also chronic 
Tuberculosis is one of the most important renal failure in the other finding was increased to 
contagious diseases in the world and 6-52.5 more than normal population [8]. 
approximately 2 million people (1/3 of world
population) are infected with mycobacterium Several studies indicated towards a higher 
tuberculosis [1]. The annual mortality rate of prevalence of TB in chronic corticosteroid 
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consumption and malignancy patients 
[9],[10],[11],[12]. 
In Iran, the incidence of reported pulmonary
tuberculosis with positive smear of sputum was 
7.8 in one hundred thousand people in 
2003(WHO had estimated 13 persons in one
hundred populations) [13]. Golestan is the second 
province for the incidence of tuberculosis in Iran
[13]. Keeping in mind the high prevalence of 
tuberculosis in our country and especially in 
Golestan province, we performed a study to 
evaluate the frequency distribution of general co 
morbidities including diabetes, chronic renal 
failure, corticosteroid consumption and
malignancy in patients with pulmonary TB, so 
that we could be aware of high risk patients, and
provide a proper base for future cohort studies
based on evaluating the incidence of pulmonary
tuberculosis in these groups. 
Materials and Methods 
In this descriptive, cross sectional study, 500 files 
of TB patients were studied. We evaluated the 
frequency distribution of diabetes, chronic renal 
failure, corticosteroid consumption, malignancies,
age and sex of documented pulmonary TB cases 
(based on definition of international tuberculosis
association) during 2001-2005 in 5th Azar 
hospital of Gorgan, Iran. Pulmonary TB was 
defined on the basis of WHO prescription; 
positive smear pulmonary TB included patients 
with 2 positive sputum smears or 1 positive
sputum smear in addition with radiological 
changes or positive sputum culture for AFB.
Negative smear pulmonary TB cases included 
patients who did not fulfill the above mentioned
criteria but were included due to specialist 
diagnosis and pulmonary radiographs and also 
those patients who didn’t have proper response to 
spectrum antibiotics but had proper response to 
antituberculosis medication , diagnosis of TB was 
established for them. Patients who had died 
without exact diagnosis or referred to other 
centers were excluded. Finally 243 patients were 
recruited. Demographic information including
sex, age, co-existing morbidities (diabetes, 
chronic renal failure/hemodialysis, corticosteroid 
consumption and malignancies) and type of 
tuberculosis and death rate were extracted from 
patient's file. Patients were categorized in 6 age 
groups, including 13-20, 21-30, 31-40, 41-50, 51­
60 and >60. Fasting blood sugar of higher than 
126 mg/dl was considered as diabetes and chronic 
renal failure/hemodialysis considered for all
hemodialized patients and also for patients who 
were suffering from renal failure during the 3 last 
month and more. Corticosteroid consumption was 
defined for the patients who took steroids with a 
dosage of more than 40 mg/day for any period of 
time; and malignancies were confirmed using 
histopathology results. All data were entered in 
the computer and analyzed with spss-11.5 
software; then one and two dimensional tables of 
frequency distribution were created and 
explained. 
Considering age and sex of patients, the patients 
were divided into two groups (one group with 
patients who had co-morbidities and the other 
who didn't have any co-existing morbidities) and
then they were compared with each other. Chi 
square and Fisher exact tests were used to explain 
the results. 
Results 
243 pulmonary TB patients were studied during 5 
years (2001-2005). Their mean (±SD) age was 
50.15 (±19) years old [Table/Fig 1]. Patients 
included 130 men (53.5%) and 113 women 
(46.5%).In our study 162 patients didn't have any 
co-existing morbidities and 81 patients (33.3%)
had at least one co-existing morbidity [Table/Fig 
2]. Diabetes was the most common co-existing 
morbidity in the study (23.05%), followed by 
chronic renal failure, corticosteroid consumption 
and malignancy (5.8%, 2.5% and 2%, 
respectively). In patients with tuberculosis and 
malignancy, cervix cancer (one case), non­
Hodgkin's lymphoma (one case), bronchogenic 
carcinoma (one case), hepatocellular carcinoma 
(one case) and brain carcinoma glioblastoma (one 
case), were reported. Six patients consumed 
corticosteroids, including two cases of asthma, 
one case of rheumatoid arthritis, two cases of 
systemic lupus erythematosis (SLE) and one 
undiagnosed case. [Table/Fig 1] shows the 
frequency distribution of TB patients based on co­
morbidities.[Table/Fig 3] shows the patients who 
didn't have any co-existing morbidities, males 
were found to have higher incidence than females 
with a ratio of 58.6/41.4. Among patients with co­
existing morbidities except malignancy cases, 
females were found to have a higher incidence 
than males in diabetes, chronic renal failure and 
corticosteroid consumption with a range of 57.1,
57.1, and 66.7 respectively. Considering age 
factor patients higher than 60 years old were 
found to have a higher incidence of co-existing 
morbidities(29.6%), similar to patients with co-
morbidities such as diabetes and malignancy 
(41.1% and 40% respectively). Among the 
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patients with corticosteroid consumption a higher 
age frequency distribution was observed in 
patients that ranged 41-50 and higher than 60 
years old (33.3%),and chronic renal failure was 
mostly seen in patients who were 41-50 years old 
(35.7%). In the patients with TB and DM, female 
factor play an important role as a risk factor 
(p<0.05) but in the other groups there weren't any 
significant statistical difference between male and 
female. 
Discussion 
In a descriptive retrospective cross sectional 
study, recorded files of 243 pulmonary TB 
patients who were admitted in 5th Azar hospital 
during 2001-2005 were studied. Then the 
frequency distribution of disease and co-existing 
morbidities which were followed by tuberculosis
was estimated. Overall, males formed 53.5% of 
the patients; predominance of male among the 
patients without co- morbidities was seen (58.6%)
but in patients with co-morbidities (except 
malignancy cases), females were predominant in 
number. 
Abbasi et al reported that males formed 53% of all 
TB patients [14] which is similar to the results of 
this study. The statistical data for sex ratio of all
pulmonary TB patients in the country shows that 
51% of all pulmonary TB patients were women 
and this difference between our study and national 
figures may be due to the majority of male 
population in Golestan province or males having 
more exposure than females. Immigration might 
be a contributing factor; but this hypothesis 
requires further evaluations. Evaluating other 
factors such as alcohol/ opium consumption, and
HIV infection in Golestan population and
comparing these factors in male and female 
population may also be of significant help, but in 
our study, except for malignancy co-existing 
morbidities (diabetes, etc) were found to be more 
frequent in females. National figures report a 
prevalence of diabetes for men as 2.41% and for 
women as 3.67% [15]. In this study for patients 
with pulmonary TB and diabetes, females had a 
higher prevalence than males (f/m = 4/3) that was 
significant statistically (p<0.05). Therefore, due to 
higher prevalence of diabetes amongst females of 
this country, contemporary appearance of 
pulmonary TB with diabetes is to be expected 
more; but it seems necessary to evaluate other 
factors as well for incidence of tuberculosis in 
diabetic females. Nisapattorn and his coworkers in 
2006 reported that females had a higher 
prevalence of coexisting TB and DM than 
males[4]. 
In Gulbay et al's study which was done in a 
hospital of Ankara during 5 years (1999-2004) 
period, there wasn't any clear difference in sex 
ratio of TB patients with and without diabetes 
[16]. Perz-Guzman and his group compared 202 
pulmonary TB patients with co-existing diabetes 
with 226 patients of pulmonary tuberculosis who 
didn't have diabetes; and their results showed that 
diabetes was more prevalent among females aged 
50 years or old [17] and this study showed 
approximately similar results. In pulmonary TB 
patients with chronic renal failure females were 
found to have a higher prevalence with 57.1% and
amongst pulmonary TB patients who had
consumed corticosteroids female population had
double the prevalence as compared to males. 
Incidence of most collagen vascular diseases in 
females, which accompanies corticosteroid 
consumption, supposedly plays an important role 
in making females more prone to have pulmonary 
TB than males. Sazaki and his coworkers in 2000 
[18] performed a study on pulmonary TB patients 
who had received corticosteroids as a treatment 
for collagen vascular disease; in their study 
females had a higher prevalence similar to that of 
our study (f/m =1.5/1). Female gender might be a 
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significant factor for increasing the incidence of 
pulmonary TB in individuals with corticosteroid
consumption, chronic renal failure and diabetes, 
but this hypothesis requires further evaluations. In 
13 year article's of Coantril and his group in 
dialytic patients (1986-1999) 24 cases of 
pulmonary TB reported equal sex ratio[19]. On 
the other hand another study reported pulmonary
TB in 26 dialytic patients that included 6 women 
and 20 men [20] which is not in confirmation with
the results of this study. In review of these studies
we couldn't find any relation between sex and 
chronic renal failure. Males were more prevalent
pulmonary TB patients with malignancy by a 
fraction of F/M =2/3. In Karnak and his 
coworker's study in 1993-1995 which was about 
pulmonary TB patients who had malignancy, 
males were prevalent with a fraction of 4/6.9=f/m;
this result is also similar to our results [21]. The 
mean age of patients without co-morbidities was 
lower than mean age of all patients (47.3 against 
50.15), against the patients with co–morbidities
(for example in diabetes 58.4 against 50.15) 
which is due to higher occurrence of co-
morbidities in elderly age. Higher age frequency 
distribution of TB patients in groups without co-
morbidity, patients with diabetes and malignancy 
was over 60 years old (29.6%, 41.6% and 40% 
respectively), but in TB patients with chronic 
renal failure and corticosteroid consumption the 
higher age frequency distribution was 41-50 years 
old (35.7% and 33.3%, respectively). This study 
showed that although co-morbidities like diabetes 
and malignancy have an increased incidence in  
higher mean age TB patients than TB patients 
without co-morbidity, factors like chronic renal 
failure and corticosteroid consumption are more 
prevalent in a lower mean age group. 
In Gulbay and coworker's study [16] simultaneous 
prevalence of pulmonary TB with diabetes for 
patients with mean age 50 years or older (21.3%)
was more than for other age groups. In Perz-
Guzman and his group's study [17] diabetes had 
higher incidence of tuberculosis in patients with
age more than 50 years. Accompaniment of
diabetes with tuberculosis in our study was 23.8% 
which was higher in Gulbay's study(17.7%) [16] 
and in Yamagishi's study(13.2%) [22]; this might 
be because of higher prevalence of pulmonary TB 
in Golestan province than the total national
prevalence. In 2003 the incidence of pulmonary 
TB with positive smear was 7.8 for 1,00,000 
patients in Iran and was reported 22 of 100000
patients in Golestan province [13]. Amongst the  
four common co-morbidities accompanying 
tuberculosis, chronic renal failure was the second 
most common with a prevalence of 6%. In 1999,  
Leung and his coworkers in Hong Kong reported 
the prevalence of pulmonary TB in long term 
consumers of corticosteroid to be 1.2% [23], 
while this amount in Cobashy study in 1999 on 
162 patients was reported as almost 3.1% [9]. Our 
findings about corticosteroid consumption and it’s 
relation with pulmonary TB was situated between 
these two ranges (2.5%). Another common co-
morbidity in our patients was malignancy with a 
prevalence of 2%. In Kamboj study in 2006 the 
rate of TB among solid organ and blood cancers 
were reported 102 and 457/100000 cases 
respectively, although this rate in normal New 
York population was 24-39/100000 [12]. 
Leung and coworker's study in 1999 found 4.2% 
of TB patients with co-existing malignancy (23). 
This incidence was 10% in Jihad's study in Saudi 
Arabia [24]. 
Restrepo BI et al in their study found preliminary
evidence of an altered immune response to M. 
tuberculosis in type 2 diabetes, especially type 2 
diabetes involving chronic hyperglycemia. 
Conclusion 
The results of this study are similar to studies
performed in other Asian countries such as Saudi 
Arabia, Korea and Japan regarding the prevalence 
of co-existing morbidities with pulmonary TB.    
Considering the higher prevalence of TB in this
region, regular screening of TB patients for DM
and Renal Failure should be considered. Also 
screening for possible co-existing pulmonary TB 
in high risk groups (DM, malignancy, chronic 
renal failure, corticosteroid treatment) by means 
of chest radiography and sputum smear should be 
considered.  
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